WeChat Mini Program
Old Version Features

Supplementary Table S9 from Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, As Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies

Benedito A. Carneiro,Ludimila Cavalcante,Devalingam Mahalingam,Anwaar Saeed,Howard Safran,Wen Wee Ma,Andrew L. Coveler,Steven Powell,Bruno Bastos,Elizabeth Davis,Vaibhav Sahai,William Mikrut,James Longstreth,Sheri Smith,Taylor Weisskittel,Hu Li,Brittany A. Borden,R. Donald Harvey,Solmaz Sahebjam,Andrés Cervantes,Austin Koukol,Andrew P. Mazar,Neeltje Steeghs,Razelle Kurzrock,Francis J. Giles,Pamela Munster

crossref（2024）

Cited 0|Views0
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined